Výsledky vyhledávání - "Simran K Tiwana"

Akademický článek

P1696: ECONOMIC BURDEN IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) FOR PATIENTS WITH ≥2 PRIOR LINES OF THERAPY INCLUDING A BRUTON TYROSINE KINASE INHIBITOR (BTKI) AND/OR B-CELL LYMPHOMA 2 INHIBITOR (BCL2I)

Autor: Masoom Priyadarshini, Gaurav Deshpande, Simran K Tiwana, T. Kim Le, Sean Garrison, Farrukh Awan

Publikováno v: HemaSphere, Vol 7, p e8677199 (2023)

Externí odkaz: https://doaj.org/article/17e2a0a5df7943318feb251e0ab18561

Zobrazit plný text záznamu

Akademický článek

PB2696: QUALITATIVE INTERVIEWS TO DESCRIBE BURDEN IN PATIENTS (PT) WITH THIRD-LINE OR LATER CLL/SLL WITH PRIOR EXPOSURE TO BRUTON TYROSINE KINASE INHIBITOR (BTKI) AND/OR B-CELL LYMPHOMA 2 INHIBITOR (BCL2I)

Autor: Masoom Priyadarshini, Zaneta Balantac, Simran K Tiwana, Shweta S Bapat, Sean Garrison, Mona L Martin

Publikováno v: HemaSphere, Vol 7, p e023224f (2023)

Externí odkaz: https://doaj.org/article/5c3cc3480cc644fb9f3c8425085178e2

Zobrazit plný text záznamu

Real-World Treatment (Tx) Patterns and Clinical Outcomes Among Patients (Pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Received at Least 2 Prior Lines of Therapy Including Bruton Tyrosine Kinase Inhibitor (BTKi) and/or B-Cell Lymphoma 2 Inhibitor (BCL2i)

Autor: Farrukh T. Awan, Gaurav A. Deshpande, Trong Kim Le, Sean Garrison, Simran K. Tiwana, Masoom Priyadarshini

Publikováno v: Blood. 140:7028-7029

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3062be38f2eb395856eefb1831e14ef9
https://doi.org/10.1182/blood-2022-159195

Zobrazit plný text záznamu